Page last updated: 2024-10-28

hydroxychloroquine and Histiocytosis, Langerhans-Cell

hydroxychloroquine has been researched along with Histiocytosis, Langerhans-Cell in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, YJ1
Hao, F1
Zhou, CL1
Sun, RS1
Xiang, MM1
Wang, JW1
Zhong, BY1
Ye, QY1
Liu, RQ1

Other Studies

1 other study available for hydroxychloroquine and Histiocytosis, Langerhans-Cell

ArticleYear
Generalized eruptive histiocytosis: a possible therapeutic cure?
    The British journal of dermatology, 2004, Volume: 150, Issue:1

    Topics: Adult; Dermatologic Agents; Drug Therapy, Combination; Facial Dermatoses; Histiocytosis, Langerhans-

2004